← Leaderboards
Alexander Constantine Loukas
Albert B. Sabin Vaccine Institute
$1,675,216
Attributed
$5,166,085
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $673.7K · FY2011–25$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,166,085 · 2
By mechanism
R01$4,604,335 · 1
R56$561,750 · 1
Top collaborators
- Paul J Brindley15 shared
- Thewarach Laha9 shared
- Jason P Mulvenna6 shared
- Jeffrey M Bethony1 shared
- Peter J Hotez1 shared
- Charles R Middaugh1 shared
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularParasitesInfectionLinkProteinsCountryFoodborneIn VivoLaosCancer VaccinesBile DuctCarcinogensCell ProliferationFar EastHelminthsIncidenceBile Duct CarcinomaBiliaryCarcinogenesisFasciola HepaticaHamstersCholangiocyteCarcinogenicityCholangiocarcinoma
Grant awards (16)
Anti-cancer vaccine targeting the host-parasite interface during fluke infection$151,875
R01 · FY2025 · CA
Anti-cancer vaccine targeting the host-parasite interface during fluke infection$139,050
R01 · FY2025 · CA
Anti-cancer vaccine targeting the host-parasite interface during fluke infection$56,808
R01 · FY2025 · CA
Anti-cancer vaccine targeting the host-parasite interface during fluke infection$382,600
R01 · FY2024 · CA
Targeting parasite-host communication to combat liver fluke-induced bile duct cancer$326,864
R01 · FY2022 · CA
Targeting parasite-host communication to combat liver fluke-induced bile duct cancer$334,003
R01 · FY2021 · CA
Targeting parasite-host communication to combat liver fluke-induced bile duct cancer$334,942
R01 · FY2020 · CA
Targeting parasite-host communication to combat liver fluke-induced bile duct cancer$525,697
R01 · FY2019 · CA
Targeting parasite-host communication to combat liver fluke-induced bile duct cancer$673,652
R01 · FY2018 · CA
Role of liver fluke granulin in cholangiocarcinogenesis$328,400
R01 · FY2016 · CA
Role of liver fluke granulin in cholangiocarcinogenesis$328,400
R01 · FY2015 · CA
Role of liver fluke granulin in cholangiocarcinogenesis$243,481
R01 · FY2014 · CA
Role of liver fluke granulin in cholangiocarcinogenesis$308,696
R01 · FY2013 · CA
Role of liver fluke granulin in cholangiocarcinogenesis$75,067
R01 · FY2013 · CA
Role of liver fluke granulin in cholangiocarcinogenesis$394,800
R01 · FY2012 · CA
PRODUCT DEVELOPMENT OF A MEMBRANE TETRASPANIN VACCINE AGAINST SCHISTOSOMIASIS$561,750
R56 · FY2011 · AI